The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease
Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal C conjugate vaccine
Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles
Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? Experience from the Netherlands
Construction of opa-positive and opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine